SM
AKTX

Sabby Management’s Akari Therapeutics AKTX Stock Holding History

Sabby Management’s Portfolio AKTX Stock Details AKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,495
Closed -$210K – 41
2025
Q2 		$210K Buy
+4,495
New +$227K 0.38% 24
2024
Q2 		– Sell
-1,212
Closed -$90.4K – 40
2024
Q1 		$90.4K Sell
1,212
-2,889
-70% -$279K 0.05% 35
2023
Q4 		$512K Sell
4,101
-351
-8% -$46.4K 0.51% 9
2023
Q3 		$703K Sell
4,452
-4,788
-52% -$741K 0.51% 9
2023
Q2 		$1.26M Sell
9,240
-687
-7% -$99.3K 1.03% 7
2023
Q1 		$1.44M Buy
9,927
+5,342
+117% +$1.68M 1.26% 5
2022
Q4 		$1.72M Sell
4,585
-544
-11% -$225K 1.51% 9
2022
Q3 		$2.58M Buy
+5,129
New +$4.22M 3.26% 9
2017
Q1 		– Sell
-22
Closed -$120K – 261
2016
Q4 		$120K Hold
22
– – 0.01% 263
2016
Q3 		$148K Hold
22
– – 0.01% 281
2016
Q2 		$235K Sell
22
-29
-57% -$374K 0.01% 239
2016
Q1 		$606K Buy
+51
New +$529K 0.03% 199
2015
Q1 		– Sell
-67
Closed -$2.59K – 289
2014
Q4 		$2.59K Sell
67
-41
-38% -$1.79M 0.08% 106
2014
Q3 		$5.06K Buy
108
+6
+6% +$280K 0.19% 63
2014
Q2 		$4.51M Buy
102
+18
+21% +$824K 0.19% 65
2014
Q1 		$4.34M Buy
+84
New +$4.75M 0.24% 71

Other funds holding AKTX

CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
OFW
Omnia Family Wealth Aventura, Florida $373M AUM 25.3% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
ACM
Accent Capital Management Centerville, Ohio $206M AUM 29.56% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Sabby Management's AKTX Position: Q3 2025 in Review

Sabby Management sold out of Akari Therapeutics (AKTX) in Q3 2025, closing a stake of 4,495 shares — an estimated $210K sold.

Sabby Management first reported a position in AKTX in Q1 2014 and held it in 16 quarters. The position peaked at $4.51M in Q2 2014. 14 funds tracked by Wall St. Rank hold AKTX as of Q3 2025.

  • Sabby Management reported no remaining Akari Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Sabby Management sold 4,495 Akari Therapeutics shares in Q3 2025, an estimated $210K.
  • Sabby Management first reported a position in Akari Therapeutics in Q1 2014 and held it in 16 quarters.
  • Sabby Management's Akari Therapeutics position peaked at $4.51M in Q2 2014.
  • 14 funds tracked by Wall St. Rank held Akari Therapeutics as of Q3 2025.

Based on Sabby Management's 13F filing for Q3 2025, filed 14 Nov 2025.